China NT Pharma Group Announces Corporate Reorganization and Business Restructuring
China NT Pharma Group Co. Ltd. has announced a corporate reorganization and business restructuring, focusing on innovative digital health services and bone health education. The company has disposed of its pharmaceutical manufacturing business to attract a wider customer base and deliver reliable returns. Shareholders and potential investors are advised to exercise caution when dealing in the company’s shares.
China NT Pharma Group Co. Ltd. has announced a corporate reorganization as part of its comprehensive new business layout following two to three years of business preparation. The Group has made a series of adjustments and restructurings to its business operations over the past fiscal years, including the disposal of its pharmaceutical manufacturing business. These strategic changes are aimed at attracting a wider customer base and delivering reliable returns, as the company shifts focus towards innovative digital health services and bone health education. Shareholders and potential investors are advised to exercise caution when dealing in the company’s shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China NT Pharma Group Co. Ltd. published the original content used to generate this news brief via via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251124-11926632), on November 24, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)
